Completed
Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine
NCT02868073
- Conditions
- Norovirus Gastroenteritis
- Locations
-
- Celerion, Inc. Lincoln, Nebraska, United States